Pre-Open Stock Movers:

The ExOne Company (NASDAQ: XONE) 42.4% HIGHER; Desktop Metal, Inc. (NYSE: DM) and The ExOne Company (NASDAQ: XONE) (ExOne) announced today they have entered into a definitive agreement pursuant to which Desktop Metal will acquire all of the issued and outstanding shares of ExOne common stock. Under the terms of the agreement, ExOne shareholders will receive $8.50 in cash and $17.00 in shares of Desktop Metal common stock for each share of ExOne common stock, for a total consideration of $25.50 per share, representing a transaction value of $575 million.

MedAvail Holdings, Inc (NASDAQ: MDVL) 33.4% LOWER; reported Q2 EPS of ($0.32), $0.02 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $5 million versus the consensus estimate of $4.8 million. Reduces outlook.

Opendoor (NASDAQ: OPEN) 20.9% HIGHER; reported Q2 EPS of ($0.24), $0.10 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.06 billion. Opendoor sees Q3 2021 revenue of $1.8-1.9 billion, versus the consensus of $1.52 billion.

1stdibs.Com, Inc. (NASDAQ: DIBS) 15.8% LOWER; reported Q2 EPS of ($0.44), versus ($0.63) reported last year. Revenue for the quarter came in at $24.7 million, versus $19.13 million reported last year. 1stdibs.Com, Inc. sees Q3 2021 revenue of $23.6-24.3 million.

PLAYSTUDIOS, Inc (NASDAQ: MYPS) 13.4% LOWER; reported Q2 EPS of ($0.07), $0.07 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $70.8 million versus the consensus estimate of $72.07 million. PLAYSTUDIOS, Inc sees FY2021 revenue of $290-300 million, versus the consensus of $327 million.

Hims & Hers Health, Inc. (NYSE: HIMS) 11.5% HIGHER; reported Q2 EPS of ($0.05), $0.05 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $60.7 million versus the consensus estimate of $56.49 million. Hims & Hers Health, Inc. sees FY2021 revenue of $251-255 million, versus the consensus of $226.3 million.

Palantir (NYSE: PLTR) 9% HIGHER; reported Q2 EPS of $0.04, $0.01 better than the analyst estimate of $0.03. Revenue for the quarter came in at $376 million versus the consensus estimate of $353.23 million. Palantir sees Q3 2021 revenue of $385 million, versus the consensus of $376.4 million.

Cano Health (NYSE: CANO) 8.9% HIGHER; reported Q2 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $393.2 million versus the consensus estimate of $300.09 million.

Dillard's (NYSE: DDS) 6.5% HIGHER; reported Q2 EPS of $8.81, versus ($0.37) reported last year. Revenue for the quarter came in at $1.57 billion, versus $919 million reported last year.

Alpha & Omega (NASDAQ: AOSL) 6.2% HIGHER; reported Q4 EPS of $0.95, $0.19 better than the analyst estimate of $0.76. Revenue for the quarter came in at $177.3 million versus the consensus estimate of $170.3 million.

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) 6% HIGHER; announced that the Food and Drug Administration (FDA) has allowed the Investigational New Drug Application (IND) for its XeriSol levothyroxine for hypothyroidism to proceed. The active IND enables Xeris to initiate a Phase 1 clinical study for XP-8121 using its novel formulation of levothyroxine in a subcutaneous injection for the treatment of hypothyroidism. The Phase 1 study will characterize Pharmacokinetics (PK) and evaluate the safety and tolerability of XP-8121 in healthy participants.

Lordstown Motors (NASDAQ: RIDE) 5.6% HIGHER; reported Q2 EPS of ($0.61), $0.15 worse than the analyst estimate of ($0.46). The company reported no sales. Said they are on track to begin limited production at the end of September and through the fourth quarter.

Clover Health Investments (NASDAQ: CLOV) 4.6% HIGHER; reported Q2 revenue of $412.5 million, versus $172.1 million reported last year.

Micron Technology (NASDAQ: MU) 3% LOWER; Morgan Stanley downgraded from Overweight to Equalweight with a price target of $75.00 (from $105.00).

Vroom (NASDAQ: VRM) 2.6% LOWER; reported Q2 EPS of ($0.48), in-line with the analyst estimate of ($0.48). Revenue for the quarter came in at $761.89 million versus the consensus estimate of $637.99 million.

Baidu (NASDAQ: BIDU) 2.4% LOWER; reported Q2 EPS of $2.39, $0.32 better than the analyst estimate of $2.07. Revenue for the quarter came in at $4.86 billion versus the consensus estimate of $4.78 billion. Baidu sees Q3 2021 revenue of $4.7-5.2 billion, versus the consensus of $5.14 billion.

Coursera (NYSE: COUR) 1.2% LOWER; Block Trade is Said Offered Via Morgan Stanley at $36.75 to $37.25 - Bloomberg